Allorecognition of HLA-DP by CD4+ T cells is affected by polymorphism in its alpha chain

Molecular Immunology

Volumn 59, Issue 1, 2014, Pages 19-29

  Lauterbach, Nina ^a   Crivello, Pietro ^b   Wieten, Lotte ^a   Zito, Laura ^b   Groeneweg, Mathijs ^a   Voorter, Christina E M ^a   Fleischhauer, Katharina ^b,c   Tilanus, Marcel G J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Allorecognition; HLA DPA1; HLA DPB1

Indexed keywords

AMINO ACID; CD137 ANTIGEN; HLA DP ANTIGEN; HLA DPA1 ANTIGEN; HLA DPB1 ANTIGEN; UNCLASSIFIED DRUG;

ALLELE; ALLOIMMUNITY; ALPHA CHAIN; ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; EXON; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; STRUCTURAL HOMOLOGY; UPREGULATION;

ALLORECOGNITION; HLA-DPA1; HLA-DPB1;

ALLELES; CELL LINE; EXONS; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA-DP ALPHA-CHAINS; HLA-DP ANTIGENS; HLA-DP BETA-CHAINS; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES;

EID: 84892841330     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2013.12.006     Document Type: Article

References (61)

1. Amendola M., Venneri M.A., Biffi A., Vigna E., Naldini L. Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters. Nat Biotechnol 2005, 23:108-116.
2. Begovich A.B., Moonsamy P.V., Mack S.J., Barcellos L.F., Steiner L.L., et al. Genetic variability and linkage disequilibrium within the HLA-DP region: analysis of 15 different populations. Tissue Antigens 2001, 57:424-439.
3. Billen E.V., Christiaans M.H., Doxiadis I.I., Voorter C.E., van den Berg-Loonen E.M. HLA-DP antibodies before and after renal transplantation. Tissue Antigens 2010, 75:278-285.
4. Cammarota G., Scheirle A., Takacs B., Doran D.M., Knorr R., et al. Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules. Nature 1992, 356:799-801.
5. Castelli F.A., Buhot C., Sanson A., Zarour H., Pouvelle-Moratille S., et al. HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity. J Immunol 2002, 169:6928-6934.
6. Cesbron A., Moreau P., Cheneau M.L., Cury S., Milpied N., et al. Crucial role of the third and fourth hypervariable regions of HLA-DPB1 allelic sequences in primary mixed-lymphocyte reaction: application in allogeneic bone marrow transplantation. Transplant Proc 1993, 25:1232-1233.
7. Cresswell P. Assembly, transport and function of MHC class II molecules. Annu Rev Immunol 1994, 12:259-293.
8. Crivello P., Lauterbach N., Zito L., Sizzano F., Toffalori C., et al. Effects of transmembrane region variability on cell surface expression and allorecognition of HLA-DP3. Hum Immunol 2013, 74:970-977.
9. Crocchiolo R., Zino E., Vago L., Oneto R., Bruno B., et al. Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. Blood 2009, 114:1437-1444.
10. Diaz G., Amicosante M., Jaraquemada D., Butler R.H., Guillén M.V., et al. Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding. Int Immunol 2003, 15:565-576.
11. Dong R.P., Kamikawaji N., Toida N., Fujita Y., Kimura A., et al. Characterization of T cell epitopes restricted by HLA-DP9 in streptococcal M12 protein. J Immunol 1995, 154:4536-4545.
12. Eapen M., Rocha V., Sanz G., Scaradavou A., Zhang M.J., et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol 2010, 11:653-660.
13. Field J., Browning S.R., Johnson L.J., Danoy P., Varney M.D., et al. A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosis. PLoS One 2010, 5:e13454.
14. Fleischhauer K., Zino E., Mazzi B., Sironi E., Servida P., et al. Peripheral blood stem cell allograft rejection mediated by CD4(+) T lymphocytes recognizing a single mismatch at HLA-DP beta 1*0901. Blood 2001, 98:1122-1126.
15. Fleischhauer K., Shaw B.E., Gooley T., Malkki M., Bardy P., et al. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. Lancet Oncol 2012, 13:366-374.
16. Fleury S., Thibodeau J., Croteau G., Labrecque N., Aronson H.E., et al. HLA-DR polymorphism affects the interaction with CD4. J Exp Med 1995, 182:733-741.
17. Flomenberg N., Baxter-Lowe L.A., Confer D., Fernandez-Vina M., Filipovich A., et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004, 104:1923-1930.
18. Gaston J.S., Goodall J.C., Young J.L., Young S.P. Effect of polymorphism of the HLA-DPA1 chain on presentation of antigenic peptides. Hum Immunol 1997, 54:40-47.
19. Gaubin M., Houlgatte R., Dettin M., Scarinci C., Martin M., et al. Definition of the alpha 2 region of HLA-DR molecules involved in CD4 binding. Hum Immunol 1999, 60:273-281.
20. Goral S., Prak E.L., Kearns J., Bloom R.D., Pierce E., et al. Preformed donor-directed anti-HLA-DP antibodies may be an impediment to successful kidney transplantation. Nephrol Dial Transplant 2008, 23:390-392.
21. Hanvesakul R., Maillere B., Briggs D., Baker R., Larche M., et al. Indirect recognition of T-cell epitopes derived from the alpha 3 and transmembrane domain of HLA-A2. Am J Transplant 2007, 7:1148-1157.
22. Hennecke J., Wiley D.C. Structure of a complex of the human α/β T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity. J Exp Med 2002, 195:571-581.
23. Hollenbach J.A., Madbouly A., Gragert L., Vierra-Green C., Flesch S., et al. A combined DPA1 DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer. Immunogenetics 2012, 69:559-569.
24. Jolly E.C., Key T., Rasheed H., Morgan H., Butler A., et al. Preformed donor HLA-DP-specific antibodies mediate acute and chronic antibody-mediated rejection following renal transplantation. Am J Transplant 2012, 12:2845-2848.
25. Konig R., Shen X., Germain R.N. Involvement of both major histocompatibility complex class II alpha and beta chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J Exp Med 1995, 182:779-787.
26. Kovalik J.P., Singh N., Mendiratta S.K., Martin W.D., Ignatowicz L., et al. The alloreactive and self-restricted CD4+ T cell response directed against a single MHC class II/peptide combination. J Immunol 2000, 165:1285-1293.
27. Lambert N.C., Distler O., Muller-Ladner U., Tylee T.S., Furst D.E., et al. HLA-DQA1*0501 is associated with diffuse systemic sclerosis in Caucasian men. Arthritis Rheum 2000, 43:2005-2010.
28. Landais E., Morice A., Long H.M., Haigh T.A., Charreau B., et al. EBV-specific CD4+ T cell clones exhibit vigorous allogeneic responses. J Immunol 2006, 177:1427-1433.
29. Lauterbach N., Voorter C.E., Stallinga C.M., Groeneweg M., Wieten L., et al. Full-length HLA-DPB1 diversity in multiple alleles of individuals from Caucasian, Black, or Oriental origin. Tissue Antigens 2012, 79:165-173.
30. Lee S.J., Klein J., Haagenson M., Baxter-Lowe L.A., Confer D.L., et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007, 110:4576-4583.
31. Meng Z., Wang Y., Zhang G., Ke Y., Yan Y., et al. Identification of an HLA-DPB1*0501 restricted Melan-A/MART-1 epitope recognized by CD4+ T lymphocytes: prevalence for immunotherapy in Asian populations. J Immunother 2011, 34:525-534.
32. Nicholson I., Varney M., Kanaan C., Grigg A., Szer J., et al. Alloresponses to HLA-DP detected in the primary MLR: correlation with a single amino acid difference. Hum Immunol 1997, 55:163-169.
33. Nishida N., Sawai H., Matsuura K., Sugiyama M., Ahn S.H., et al. Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PLoS One 2012, 7:e39175.
34. O'Brien T.R., Kohaar I., Pfeiffer R.M., Maeder D., Yeager M., et al. Risk alleles for chronic hepatitis B are associated with decreased mRNA expression of HLA-DPA1 and HLA-DPB1 in normal human liver. Genes Immun 2011, 12:428-433.
35. Oudshoorn M., Lie J.L., Roelen D.L., Verduyn W., Claas F.H.J. Is an HLA-DRB1*1454/HLA-DRB1*1401 mismatch an acceptable mismatch in hematopoietic stem cell transplantation. Tissue Antigens 2008, 71:315-316.
36. Petersdorf E.W., Gooley T., Malkki M., Anasetti C., Martin P., et al. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation. Brit J Haematol 2001, 112:988-994.
37. Reche P.A., Reinherz E.L. Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms. J Mol Biol 2003, 331:623-641.
38. Reed A.M., Stirling J.D. Association of the HLA-DQA1*0501 allele in multiple racial groups with juvenile dermatomyositis. Hum Immunol 1995, 44:131-135.
39. Richeldi L., Sorrentino R., Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 1993, 262:242-244.
40. Robinson J., Halliwell J.A., McWilliam H., Lopez R., Parham P., et al. The IMGT/HLA database. Nucleic Acids Res 2013, 41:D1222-D1227.
41. Rutten C.E., van Luxemburg-Heijs S.A., van der Meijden E.D., Griffioen M., Oudshoorn M., et al. Both permissive and nonpermissive HLA-DPB1 mismatches can induce polyclonal HLA-DPB1 specific immune responses in vivo and in vitro. Blood 2010, 115:151-153.
42. Rutten C.E., van Luxemburg-Heijs S.A., Halkes C.J., van Bergen C.A., Marijt E.W., et al. Patient HLA-DP-specific CD4+ T cells from HLA-DPB1-mismatched donor lymphocyte infusion can induce graft-versus-leukemia reactivity in the presence or absence of graft-versus-host disease. Biol Blood Marrow Transplant 2013, 19:40-48.
43. Schaffer M., Aldener-Cannavá Remberger M., Ringdén O., Olerup O. Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation. Tissue Antigens 2003, 62:243-250.
44. Shaw B.E., Gooley T.A., Malkki M., Madrigal J.A., Begovich A.B., et al. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood 2007, 110:4560-4566.
45. Sizzano F., Zito L., Crivello P., Crocchiolo R., Vago L., et al. Significantly higher frequencies of alloreactive CD4+ T cells responding to nonpermissive than to permissive HLA-DPB1 T-cell epitope disparities. Blood 2010, 116:1991-1992.
46. Smith J.G., Liu X., Kaufhold R.M., Clair J., Caulfield M.J. Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus. Clin Diagn Lab Immunol 2001, 8:871-879.
47. Straetemans T., van Brakel M., van Steenbergen S., Broertjes M., Drexhage J., et al. TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets. Clin Dev Immunol 2012, 2012:586314.
48. Thaunat O., Hanf W., Dubois V., McGregor B., Perrat G., et al. Chronic humoral rejection mediated by anti-HLA-DP alloantibodies: Insights into the role of epitope sharing in donor-specific and non-donor specific alloantibodies generation. Transpl Immunol 2009, 20:209-211.
49. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680.
50. Varney M.D., Lester S., McCluskey J., Gao X., Tait B.D. Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation. Hum Immunol 1999, 60:532-538.
51. Varney M.D., Valdes A.M., Carlson J.A., Noble J.A., Tait B.D., et al. HLA DPA1, DPB1 alleles and haplotypes contribute to the risk associated with type 1 diabetes: analysis of the type 1 diabetes genetics consortium families. Diabetes 2010, 59:2055-2062.
52. Voo K.S., Fu T., Heslop H.E., Brenner M.K., Rooney C.M., et al. Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells. Cancer Res 2002, 62:7195-7199.
53. Voorter C.E., Lauterbach N., Tilanus M.G. Inactivation of a functional HLA-A gene: a 4-kb deletion turns HLA-A*24 into a pseudogene. Hum Immunol 2010, 71:1197-1202.
54. Wallaschofski H., Meyer A., Tuschy U., Lohmann T. HLA-DQA1*0301-associated susceptibility for autoimmune polyglandular syndrome type II and III. Horm Metab Res 2003, 35:120-124.
55. Wang X., Greenfield W.W., Coleman H.N., James L.E., Nakagawa M. Use of interferon-gamma enzyme-linked immunospot assay to characterize novel T-cell epitopes of human papillomavirus. J Vis Exp: JoVE 2012, 61:3657.
56. Watts T.H. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 2005, 23:23-68.
57. Wolfl M., Kuball J., Ho W.Y., Nguyen H., Manley T.J., et al. Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. Blood 2007, 110:201-210.
58. Wonderlich J., Shearer G., Livingstone A., Brooks A. Induction and measurement of cytotoxic T lymphocyte activity. Curr protocols in immunology 2006, (Chapter 3, Unit 3 11).
59. Xiao Y., Lazaro A.M., Masaberg C., Haagenson M., Vierra-Green C., et al. Evaluating the potential impact of mismatches outside the antigen recognition site in unrelated hematopoietic stem cell transplantation: HLA-DRB1*1454 and DRB1*140101. Tissue Antigens 2009, 73:595-598.
60. Yanagawa T., Mangklabruks A., DeGroot L.J. Strong association between HLA-DQA1*0501 and Graves' disease in a male Caucasian population. J Clin Endocrinol Metab 1994, 79:227-229.
61. Zino E., Frumento G., Martktel S., Sormani M.P., Ficara F., et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood 2004, 103:1417-1424.